Press "Enter" to skip to content

New patent expiration for Janssen Prods drug EDURANT

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Prods drug EDURANT

Annual Drug Patent Expirations for EDURANT
Annual Drug Patent Expirations for EDURANT

Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

EDURANT drug price trends.

Drug patent litigation for EDURANT.

This drug has two hundred and eight patent family members in forty-one countries.

The generic ingredient in EDURANT is rilpivirine hydrochloride. One supplier is listed for this compound. Additional details are available on the rilpivirine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Prods drug EDURANT
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions